Optinose reports Q1 EPS (12c), consensus (11c)
PremiumThe FlyOptinose reports Q1 EPS (12c), consensus (11c)
2M ago
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
PremiumPress Releases
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
2M ago
OPTN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OPTN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Optinose provides corporate update on XHANCE launch
PremiumThe FlyOptinose provides corporate update on XHANCE launch
3M ago
Optinose reports preliminary Q1 XHANCE net revenue of $14.9M
PremiumThe Fly
Optinose reports preliminary Q1 XHANCE net revenue of $14.9M
3M ago
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
PremiumPress Releases
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
3M ago
OptiNose trading resumes
PremiumThe FlyOptiNose trading resumes
4M ago
OptiNose Inc: FDA Approval and Future Pediatric Study for XHANCE
PremiumCompany Announcements
OptiNose Inc: FDA Approval and Future Pediatric Study for XHANCE
4M ago
Optinose to resume trading at 4:20 pm ET
PremiumThe Fly
Optinose to resume trading at 4:20 pm ET
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100